Most Popular Brands: Voltaren, Voltaren Gel, Voltaren XR (Show all)
See also: Diclofenac Epolamine Patch
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) taken to reduce inflammation and pain in conditions such as in arthritis or acute injury. Preparations available as diclofenac sodium, diclofenac potassium, diclofenac epolamine.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Pain | 44 |
|
|
|
|
|
9 |
| Other | 16 |
|
|
|
|
8 | |
| joint pain | 12 |
|
|
3 | |||
| Inflammation, joints | 10 |
|
2 | ||||
| Inflammation | 8 |
|
1 | ||||
| Arthritis | 8 |
|
|
|
4 |
See all 107 patients currently taking Diclofenac
Mouse over the table for more information
Top 10 dosages based on patients currently taking Diclofenac. See all 32 dosages ►
| 150mg as needed | 1g as needed | 1other as needed | 25 other all the time (24/7) | 4g as needed | 50 mg as needed | 50mg as needed | 8 mg as needed | daily | sodium100mg as needed | sodium25mg as needed | sodium50mg as needed | sodium75mg as needed | 1 mg daily | 1.3 g daily | 2 g daily | 2 hr daily | 4 g daily | 4 mg daily | 4 mg one time | 6 g daily | 100 g weekly | 20 g daily | 25 mg daily | 30 mg daily | 32 g daily | 50 mg daily | 75 mg daily | 100 mg daily | 150 mg daily | 200 mg daily | 225 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
3
|
1
|
7
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
3
|
8
|
14
|
37
|
4
|
2
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
16 | 37% |
|
|
Course of treatment ended
|
8 | 19% |
|
|
Doctor's advice
|
8 | 19% |
|
|
Side effects too severe
|
6 | 14% |
|
|
Other
|
5 | 12% |
|
|
Personal research
|
2 | 5% |
|
|
Not indicated
|
1 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.